Las Vegas, NV -- (SBWIRE) -- 12/19/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Idera Pharmaceuticals Inc (NASDAQ:IDRA), ANADIGICS, Inc. (NASDAQ:ANAD), Brigus Gold Corp (USA) (NYSEMKT:BRD), Generex Biotechnology Corporation (OTCMKTS:GNBT)
Idera Pharmaceuticals Inc (NASDAQ:IDRA) managed to keep its fall at -1.71% on above-normal volume of 2.47M shares. The stock settled at $3.44 after floating in a range of $3.30 to $3.63. Its latest price has reached market capitalization of $160.74 million. Its 52-week range has been $0.19 to $3.63. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates.
Has IDRA Found The Bottom and Ready To Move Up? Find Out Here
ANADIGICS, Inc. (NASDAQ:ANAD) traded down on a volume of 2.41 million, higher than its standard daily volume. Shares have dropped3.80% to $1.77. Over the last twelve months, the stock has lost-11.5% and faced a worst price of $1.67. ANADIGICS, Inc. is a designer and manufacturer of radio frequency (RF) semiconductor solutions for cellular wireless, wireless fidelity (WiFi), and infrastructure applications.
Has ANAD Found The Bottom And Ready To Gain Momentum? Find Out Here
Brigus Gold Corp (USA) (NYSEMKT:BRD) settled 0.63% higher at $0.780 on above-normal volume of 2.27M shares during the last trading day. The stock has its 12-month high at $1 and 52-week low price was $0.41. It traded in a range of $0.76 to $0.80 during the last trading day. Brigus Gold Corp. (Brigus) is a mining company. The Company is engaged in the extraction, processing, and refining of gold deposits, as well as related activities, including the acquisition, exploration and development of mineral properties principally located in North America. Its sole mining operation is the Black Fox Mine. As of December 31, 2011, the Company was evaluating the Goldfields Project, which hosts the Box and Athona gold deposits.
Why Should Investors Buy BRD After the Recent Fall? Just Go Here and Find Out
In the last trading session, Generex Biotechnology Corporation (OTCMKTS:GNBT) showed no change on high volume, trading at a volume of 2.51M versus its average daily volume of 1.83 million shares. At $0.0290, the stock has attained market capitalization of 16.83 million. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes.
Can GNBT Show a Strong Recovery? Find out in This Research Report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)